Therefore, despite the loss of beta cells and associated LAT1 expression, no change in18F-L-FEHTP uptake could be detected, leading us to conclude that18F-L-FEHTP uptake is not a surrogate measure of changes in beta cell mass during the progression of diabetes. The gene discussed is SLC7A5; the disease is diabetes mellitus.